A carregar...
Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
OBJECTIVE: To evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on body weight in overweight and obese subjects (body mass index [BMI] ≥27 and <50 kg/m(2)). METHODS: This 12-week, Phase 2b, randomized, double-blind study enrolled 376 subjects without diabetes mel...
Na minha lista:
| Publicado no: | Obesity (Silver Spring) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4285787/ https://ncbi.nlm.nih.gov/pubmed/24227660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.20663 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|